Skip to main content
CARE
NASDAQ Finance

Carter Bankshares Q3 EPS Falls to $0.35 From $1.31 as Charge-Offs Hit $12.1M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$30.29
Mkt Cap
$669.794M
52W Low
$16.78
52W High
$36.06
52W Position info
81% above low
Off High info
16% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CARE sits 81% above its 52-week low of $16.78.

Summary

Carter Bankshares earned $0.35 per share in Q3 2026 versus $1.31 in Q2, a gap driven mainly by $100.9 million of one-time gains booked last quarter. Core net interest income grew 3.2% and the margin widened to 3.51%, but $12.1 million of net charge-offs — including an $8.0 million C&I write-off after a borrower's Chapter 11 filing — are the number to focus on.


Key Events · Earnings and Guidance · CARE

  • Q3 EPS of $0.35 vs $1.31 in Q2

    Net income was $7.8 million, or $0.35 diluted EPS, versus $28.9 million, or $1.31, in Q2 2026 and $5.4 million, or $0.24, in Q3 2025. The linked-quarter drop largely reflects the absence of the roughly $100.9 million of aggregate nonrecurring pre-tax gains booked in the first half of 2026.

  • Net charge-offs jump to $12.1 million

    Q3 net charge-offs were $12.1 million, or 1.28% annualized of average portfolio loans, versus net recoveries of $0.7 million in Q2. The total includes an $8.0 million C&I charge-off following a borrower's voluntary Chapter 11 filing and a $4.0 million CRE charge-off after updated collateral valuations.

  • Margin expands to 3.51%, NII up 3.2%

    Net interest income rose to $41.2 million, up $1.3 million linked-quarter and $7.5 million (22.3%) year-over-year. Net interest margin widened 13 basis points to 3.51% and is up 65 basis points from 2.86% a year ago.

  • NPLs fall to $27.9 million

    Nonperforming loans declined $9.6 million to $27.9 million, or 0.74% of portfolio loans, from 1.01% at June 30, 2026. Allowance coverage of nonperforming loans rose to 191.79% from 146.88%.


Analysis · CARE · Finance

The headline number looks ugly only by comparison: Q2's $1.31 included roughly $100.9 million of one-time pre-tax gains from the loan sale and insurance transactions, so the drop to $0.35 mostly reflects the absence of those gains, not a collapse in the core bank. What actually matters is the credit line — $12.1 million of net charge-offs in the quarter, including an $8.0 million commercial and industrial write-off after a borrower filed for Chapter 11, pushed annualized charge-offs to 1.28% of average loans from net recoveries a quarter earlier. Against that, net interest income rose 3.2% to $41.2 million and the margin widened 13 basis points to 3.51%, while nonperforming loans kept falling to $27.9 million, or 0.74% of loans. The stock already trades below the $29.89 book value per share reported for September 30, so the market is pricing skepticism about credit; the next real test is whether the isolated C&I and CRE losses stay isolated in Q4.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CARE was trading at $30.29 on NASDAQ in the Finance sector, with a market capitalization of approximately $669.8M. The 52-week trading range was $16.78 to $36.06. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CARE - Latest Insights

CARE
Nov 05, 2026, 11:49 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.69
Real-time Price: $29.19 info
Change: +$0.500 (+2%) info
Market Cap: $641.307M info
CARE
Oct 29, 2026, 8:01 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $30.29
Real-time Price: $29.19 info
Change: -$1.10 (-4%) info
Market Cap: $641.307M info
CARE
Aug 06, 2026, 1:26 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $34.39
Real-time Price: $29.19 info
Change: -$5.20 (-15%) info
Market Cap: $641.307M info
CARE
Jul 23, 2026, 8:22 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $32.66
Real-time Price: $29.19 info
Change: -$3.47 (-11%) info
Market Cap: $641.307M info
CARE
Jul 23, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $32.66
Real-time Price: $29.19 info
Change: -$3.47 (-11%) info
Market Cap: $641.307M info